Valuation HOB Biotech Group Corp.,Ltd
Stocks
688656
CNE100004C37
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.56 CNY | -5.33% |
|
-12.09% | -40.47% |
Company Valuation: HOB Biotech Group Corp.,Ltd
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Market Cap 1 | 3,973 | 2,114 | 2,192 | 5,946 | 9,640 |
| Change | - | -46.79% | 3.7% | 171.25% | 62.14% |
| Enterprise Value (EV) 1 | 3,549 | 1,890 | 2,084 | 5,940 | 9,624 |
| Change | - | -46.74% | 10.27% | 184.97% | 62.03% |
| P/E | 45x | 50.8x | 47x | 165x | 416x |
| PBR | 5.16x | 2.71x | 2.7x | 7.32x | 11.8x |
| PEG | 2.7x | -1x | 3.9x | -7.6x | -11.5x |
| Capitalization / Revenue | 12.5x | 6.6x | 5.56x | 14.8x | 24.2x |
| EV / Revenue | 11.2x | 5.9x | 5.28x | 14.8x | 24.2x |
| EV / EBITDA | 34.2x | 27.4x | 24.1x | 71.3x | 120x |
| EV / EBIT | 42.1x | 45x | 38.7x | 134x | 545x |
| EV / FCF | -40.4x | -13.6x | -14.7x | -122x | -234x |
| FCF Yield | -2.47% | -7.33% | -6.79% | -0.82% | -0.43% |
| Dividend per Share 2 | 0.53 | 0.3 | 0.4 | 0.3 | 0.2 |
| Rate of return | 0.84% | 0.89% | 1.15% | 0.31% | 0.13% |
| EPS 2 | 1.4 | 0.66 | 0.74 | 0.58 | 0.37 |
| Distribution rate | 37.9% | 45.5% | 54.1% | 51.7% | 54.1% |
| Net sales 1 | 317.7 | 320.4 | 394.4 | 402.3 | 398.4 |
| EBITDA 1 | 103.9 | 68.95 | 86.55 | 83.31 | 80.36 |
| EBIT 1 | 84.33 | 42.01 | 53.85 | 44.16 | 17.67 |
| Net income 1 | 86.19 | 41.65 | 47.33 | 36.8 | 23.2 |
| Net Debt 1 | -424 | -223.6 | -107.6 | -5.932 | -15.95 |
| Reference price 2 | 63.00 | 33.52 | 34.76 | 95.50 | 153.80 |
| Nbr of stocks (in thousands) | 63,058 | 63,058 | 63,058 | 62,257 | 62,678 |
| Announcement Date | 24/04/22 | 25/04/23 | 25/04/24 | 17/03/25 | 17/03/26 |
1CNY in Million2CNY
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 846M | ||
| -54.61x | 16.38x | -119.67x | -.--% | 21B | ||
| 17.02x | 1.93x | 8.04x | 1.51% | 9.53B | ||
| 24.54x | 4.5x | 12.69x | - | 6.86B | ||
| -51.29x | 7.85x | -65.88x | -.--% | 5.3B | ||
| 18.99x | 6.51x | 14.72x | 3.03% | 5.12B | ||
| 168.46x | 4.38x | 28.46x | -.--% | 4.82B | ||
| 20.24x | 3.55x | 11.05x | 1.88% | 4.2B | ||
| 15.66x | - | - | 4.09% | 2.63B | ||
| Average | 19.88x | 6.44x | -15.80x | 1.5% | 6.7B | |
| Weighted average by Cap. | -0.88x | 8.87x | -42.93x | 0.92% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 688656 Stock
- Valuation HOB Biotech Group Corp.,Ltd
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















